EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Levodopa-induced dyskinesia in early-onset Parkinson’s disease (EOPD) associates with glucocerebrosidase mutation: A next-generation sequencing study in EOPD patients in Thailand

Sekh Thanprasertsuk, Prasit Phowthongkum, Thitipong Hopetrungraung, Chalalai Poorirerngpoom, Tikumphorn Sathirapatya, Patsorn Wichit, Onanong Phokaewvarangkul, Kornkiat Vongpaisarnsin, Saknan Bongsebandhu-Phubhakdi iD, Roongroj Bhidayasiri

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0293516 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Sekh Thanprasertsuk und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Parkinson Disease, Dyskinesias. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Council of Thailand, Thailand Science Research and Innovation Fund Chulalongkorn University, Ratchadapiseksompotch Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

With the benefit of using next-generation sequencing (NGS), our aim was to examine the prevalence of known monogenic causes in early-onset Parkinson’s disease (EOPD) patients in Thailand. The association between clinical features, such as levodopa-induced dyskinesia (LID), and genotypes were also explored.

Method

NGS studies were carried out for EOPD patients in the Tertiary-referral center for Parkinson’s disease and movement disorders. EOPD patients who had LID symptoms were enrolled in this study (n = 47). We defined EOPD as a patient with onset of PD at or below 50 years of age. LID was defined as hyperkinetic movements including chorea, ballism, dystonia, myoclonus, or any combination of these movements resulting from levodopa therapy, which could be peak-dose, off-period, or diphasic dyskinesias.

Results

Pathogenic variants were identified in 17% (8/47) of the Thai EOPD patients, of which 10.6% (5/47) were heterozygous GBA variants (c.1448T>C in 3 patients and c.115+1G>A in 2 patients), 4.3% (2/47) homozygous PINK1 variants (c.1474C>T) and 2.1% (1/47) a PRKN mutation (homozygous deletion of exon 7). The LID onset was earlier in patients with GBA mutations compared to those without (34.8±23.4 vs 106.2±59.5 months after starting levodopa, respectively, p = 0.001). LID onset within the first 30 months of the disease was also found to be independently associated with the GBA mutation (odds ratio [95% confidence interval] = 25.00 [2.12–295.06], p = 0.011).

Conclusion

Our study highlights the high prevalence of GBA pathogenic variants in Thai patients with EOPD and the independent association of these variants with the earlier onset of LID. This emphasizes the importance of genetic testing in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseDyskinesiasHumansLevodopaGlucosylceramidaseHomozygoteThailandSequence DeletionMutationHigh-Throughput Nucleotide SequencingAge of Onset

Substanzen

LevodopaGlucosylceramidase

Autor:innen und Institutionen

  • Department of Physiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Cognitive Clinical & Computational Neuroscience (CCCN) Center of Excellence, Chulalongkorn University, Bangkok, Thailand.
  • Chula Neuroscience Center, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.
  • Division of Medical Genetics and Genomics, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Excellence Center of Genomics and Precision Medicine, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.
  • Department of Medicine, Queen Savang Vadhana Memorial Hospital, Chonburi, Thailand.

ORCID-Profile: Saknan Bongsebandhu-Phubhakdi

Förderung

  • National Research Council of Thailand
  • Thailand Science Research and Innovation Fund Chulalongkorn University
  • Ratchadapiseksompotch Fund

Zitieren

APA

Thanprasertsuk, S., Phowthongkum, P., Hopetrungraung, T., Poorirerngpoom, C., Sathirapatya, T., Wichit, P., Phokaewvarangkul, O., Vongpaisarnsin, K., Bongsebandhu-Phubhakdi, S., & Bhidayasiri, R. (2023). Levodopa-induced dyskinesia in early-onset Parkinson’s disease (EOPD) associates with glucocerebrosidase mutation: A next-generation sequencing study in EOPD patients in Thailand. PLOS ONE. https://doi.org/10.1371/journal.pone.0293516

Vancouver

Thanprasertsuk S, Phowthongkum P, Hopetrungraung T, Poorirerngpoom C, Sathirapatya T, Wichit P, et al. Levodopa-induced dyskinesia in early-onset Parkinson’s disease (EOPD) associates with glucocerebrosidase mutation: A next-generation sequencing study in EOPD patients in Thailand. PLOS ONE. 2023. doi:10.1371/journal.pone.0293516

BibTeX
@article{Thanprasertsuk2023,
  author = {Thanprasertsuk, Sekh and Phowthongkum, Prasit and Hopetrungraung, Thitipong and Poorirerngpoom, Chalalai and Sathirapatya, Tikumphorn and Wichit, Patsorn and Phokaewvarangkul, Onanong and Vongpaisarnsin, Kornkiat and Bongsebandhu-Phubhakdi, Saknan and Bhidayasiri, Roongroj},
  title = {Levodopa-induced dyskinesia in early-onset Parkinson’s disease (EOPD) associates with glucocerebrosidase mutation: A next-generation sequencing study in EOPD patients in Thailand},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0293516}
}
Kostenlos starten →